Evidence map›Paper›PMID 30679432›Full record

ArticleNature communications2019

Contribution of rare and common variants to intellectual disability in a sub-isolate of Northern Finland.

Mitja I Kurki, Elmo Saarentaus, Olli Pietiläinen, Padhraig Gormley, Dennis Lal, Sini Kerminen, Minna Torniainen-Holm, Eija Hämäläinen, Elisa Rahikkala, Riikka Keski-Filppula and 16 more

Abstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Clinical and genetic characterization of intellectual disability.Developmental medicine and child neurology · 2026
    Article
  2. Article
  3. Joint analysis ofNAR genomics and bioinformatics · 2025
    Article
  4. Article
  5. Phenotypic Heterogeneity in Genetic and Acquired Pediatric Cerebellar Disorders.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  6. Article
  7. NovelInternational journal of molecular sciences · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Mitja I KurkiPsychiatric & Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, MA, 02114, USA.
Elmo SaarentausInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, FI-00014, Helsinki, Finland.ORCID http://orcid.org/0000-0002-8475-7187
Olli PietiläinenThe Stanley Center for Psychiatric Research, The Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
Padhraig GormleyPsychiatric & Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, MA, 02114, USA.ORCID http://orcid.org/0000-0002-8908-6968
Dennis LalPsychiatric & Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, MA, 02114, USA.
Sini KerminenInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, FI-00014, Helsinki, Finland.
Minna Torniainen-HolmInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, FI-00014, Helsinki, Finland.
Eija HämäläinenInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, FI-00014, Helsinki, Finland.
Elisa RahikkalaPEDEGO Research Unit, University of Oulu, FI-90014, Oulu, Finland.
Riikka Keski-FilppulaPEDEGO Research Unit, University of Oulu, FI-90014, Oulu, Finland.
Merja RauhalaNorthern Ostrobothnia Hospital District, Center for Intellectual Disability Care, 90220, Oulu, Finland.
Satu Korpi-HeikkiläNorthern Ostrobothnia Hospital District, Center for Intellectual Disability Care, 90220, Oulu, Finland.
Jonna Komulainen-EbrahimDepartment of Children and Adolescents, Oulu University Hospital, Medical Research Center Oulu, University of Oulu, FI-90029, Oulu, Finland.
Heli HelanderDepartment of Children and Adolescents, Oulu University Hospital, Medical Research Center Oulu, University of Oulu, FI-90029, Oulu, Finland.
Päivi VieiraDepartment of Children and Adolescents, Oulu University Hospital, Medical Research Center Oulu, University of Oulu, FI-90029, Oulu, Finland.
Minna MännikköCenter for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.
Markku PeltonenNational Institute for Health and Welfare, 00271, Helsinki, Finland.
Aki S HavulinnaInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, FI-00014, Helsinki, Finland.
Veikko SalomaaNational Institute for Health and Welfare, 00271, Helsinki, Finland.ORCID http://orcid.org/0000-0001-7563-5324
Matti PirinenInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, FI-00014, Helsinki, Finland.ORCID http://orcid.org/0000-0002-1664-1350
Jaana SuvisaariNational Institute for Health and Welfare, 00271, Helsinki, Finland.ORCID http://orcid.org/0000-0001-7167-0990
Jukka S MoilanenPEDEGO Research Unit, University of Oulu, FI-90014, Oulu, Finland.
Jarmo KörkköNorthern Ostrobothnia Hospital District, Center for Intellectual Disability Care, 90220, Oulu, Finland.
Outi KuisminInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, FI-00014, Helsinki, Finland.
Mark J DalyPsychiatric & Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, MA, 02114, USA.
Aarno PalotiePsychiatric & Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, MA, 02114, USA. aarno.palotie@helsinki.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The contribution of de novo variants in severe intellectual disability (ID) has been extensively studied whereas the genetics of mild ID has been less characterized. To elucidate the genetics of milder ID we studied 442 ID patients enriched for mild ID (>50%) from a population isolate of Finland. Using exome sequencing, we show that rare damaging variants in known ID genes are observed significantly more often in severe (27%) than in mild ID (13%) patients. We further observe a significant enrichment of functional variants in genes not yet associated with ID (OR: 2.1). We show that a common variant polygenic risk significantly contributes to ID. The heritability explained by polygenic risk score is the highest for educational attainment (EDU) in mild ID (2.2%) but lower for more severe ID (0.6%). Finally, we identify a Finland enriched homozygote variant in the CRADD ID associated gene.

Indexed as

Cognitive DysfunctionCohort StudiesCRADD Signaling Adaptor ProteinDNA Copy Number VariationsExomeExome SequencingFemaleFinlandGenetic Association StudiesGenetic Diseases, InbornGenetic Predisposition to DiseaseGenetic VariationGenome, HumanGeographyHomozygoteHumansCRADD protein, humanCRADD Signaling Adaptor Protein

Identifiers

PMID30679432
PMCPMC6345990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.